OMT is developing a non-invasive technology that take advantage of basic cell mechanisms to provide a safe and effective treatment for late-stage cancers.
Oleander Medical Team was grateful to help provide continuing education credits for a local Veterinary Association. Thanks to Monroe Street Animal Hospital for the invitation. Big shout out to Dr. Whitney, Dr. Johnson and Young's SteakHouse for hosting this great event.
Thank you for all the support this year! We had a lot of great progress with TOL and looking forward to what 2022 will bring! Merry Christmas and Happy New Year!! #cancerresearch#medicaldevice#TOL
Stay ahead of the curve with Pathfinders, a new podcast from RBC Capital Markets for companies and investors in biopharma. Start listening now.Inside Track: Behind the Scenes of a Major Biotech SPAC https://t.co/rJyUTxkskG Great Stuff Here!!
Today we announced an update on our phase 3 pivotal LUNAR trial of Tumor Treating Fields as a treatment for non-small cell lung cancer: https://t.co/wiZ4HuEnDN. #lungcancer#lcsm
Our new website is easy to navigate and full of updated information about our progress in demonstrating the potential of TOL as a noninvasive breakthrough treatment for advanced cancer. Go to: https://t.co/7Yz6oCdpJJ #newwebsite#TOL#oncology#Medicaldevices
Thanks to Phantom Labs and Richard Mallozzi for the design and manufacturing of our new treatment device large enough for any size human currently being used @MSAH101 on Dogs and Cats. #CancerResearch#medicaldevices#PetOncology
Today our next prototype was shipped from Upstate New York. We'll immediately try it on cell culture and mice to learn the right protocol for using it. By mid-June, we should be trying it on dogs and cats. #medicaldevices#oncology
This past weekend was a big milestone day for our company, a day to savor and remember! Our first Prototype for treating advanced cancer in dogs and cats. #CancerResearch#CureCancer